Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.720
-0.010 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
1.740
+0.020 (1.16%)
After-hours: Dec 5, 2025, 6:49 PM EST
Climb Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 117 | 121 | 74 | 98 | 278 | - | |
| Market Cap Growth | -46.32% | 62.54% | -23.65% | -64.90% | - | - | |
| Enterprise Value | -58 | -97 | -33 | -32 | 108 | - | |
| Last Close Price | 1.72 | 1.80 | 2.70 | 3.67 | 10.46 | - | |
| PB Ratio | 0.66 | 0.57 | 0.69 | 0.76 | 1.66 | - | |
| P/TBV Ratio | 0.66 | 0.57 | 0.69 | 0.76 | 1.66 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | - | - | |
| Quick Ratio | 17.56 | 30.83 | 38.57 | 21.35 | 23.79 | 8.16 | |
| Current Ratio | 18.38 | 31.41 | 38.92 | 22.04 | 24.58 | 8.76 | |
| Return on Equity (ROE) | -25.65% | -46.26% | -29.72% | -30.58% | -50.16% | -96.73% | |
| Return on Assets (ROA) | -17.35% | -10.30% | -10.93% | -18.30% | -22.54% | -31.96% | |
| Return on Capital (ROIC) | -17.70% | -10.54% | -11.31% | -19.04% | -23.55% | -34.42% | |
| Return on Capital Employed (ROCE) | -31.70% | -12.70% | -19.90% | -35.00% | -21.30% | -53.20% | |
| Earnings Yield | -43.27% | -61.07% | -47.17% | -46.40% | -17.09% | - | |
| Buyback Yield / Dilution | -76.96% | -78.47% | -2.57% | -114.60% | -460.40% | -31.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.